ingenol mebutate · Medicine question

Why was it taken off the market?

iatroX medicinesPublished 20 August 2026Reviewed 20 August 2026

The answer

Answer

Clinical evidence showed more skin tumours in treated areas than with comparator treatment. The European review concluded that the risks outweighed the benefits.

Sources for this answer

European Medicines AgencyEuropean Medicines Agency · Reputable Web

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

Is ingenol mebutate still available in the UK?What was it used to treat?Is actinic keratosis skin cancer?What skin changes matter after previous treatment?What if it gets into an eye?What if it is swallowed?

loading page…

Answer

Sources for this answer

More questions about ingenol mebutate

Answer

Sources for this answer

More questions about ingenol mebutate

More clinical questions?